Scott Cross

Scott Cross is a seasoned professional in the field of gene therapy and vector operations, currently serving as Senior Principal and Head of Gene Therapy CMC at Dark Horse Consulting Group Inc. since January 2020. Prior roles include Vice President of Vector Operations and Senior Director of Vector Manufacturing at Orchard Therapeutics, as well as Director of Cell Therapy at Florida Biologix. Scott has successfully managed various aspects of vector production and cell therapy operations, emphasizing regulatory compliance and process development across multiple organizations, including Cincinnati Children's Hospital and Indiana University. With a strong background in microbiology and a Master’s degree in Biological Sciences from Western Michigan University, Scott has a proven track record in overseeing clinical research projects, ensuring quality assurance, and driving innovation in the biopharmaceutical industry.